| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Institute of Dermatologic Science and IRCCS
Ospedale Maggiore,*
Milan, Italy; the Department of
Dermatology,
Ospedale Busto Arsizio, Italy;
and the Departments of Dermatology and
Pathology,
Free University Hospital,
Amsterdam, The Netherlands
Cutaneous T cell lymphomas (CTCL) generally have the phenotype of
CD3+, CD4+, CD45RO+ memory T cells. CTCL expressing a
CD8+ T cell phenotype are extremely rare and ill-defined. To elucidate
whether these CD8+ CTCL represent a distinct disease entity,
the clinical, histological, and immunophenotypical
features of 17 CD8+ CTCL were reviewed. None of the 17 cases expressed
markers characteristic of natural killer cells or 
/
T cells. Nine
of 17 cases showed the characteristic clinical and histological
features as well as clinical behavior of well defined types of
CTCL, such as mycosis fungoides (2 cases), pagetoid
reticulosis (2 cases), lymphomatoid papulosis (2
cases), and CD30+ large T cell lymphoma (2
cases), all of which usually express a CD4+ T cell
phenotype, and 1 case of subcutaneous panniculitis-like T cell
lymphoma. The other 8 cases formed a homogeneous group showing a
distinctive set of clinicopathological and immunophenotypical
features, not consistent with that of other well defined types
of CTCL. Clinical characteristics included presentation with
generalized patches, plaques, papulonodules,
and tumors mimicking disseminated pagetoid reticulosis; metastatic
spread to unusual sites, such as the lung,
testis, central nervous system, and oral
cavity, but not to the lymph nodes; and an aggressive course
(median survival, 32 months). Histologically, these
lymphomas were characterized by band-like infiltrates consisting of
pleomorphic T cells or immunoblasts, showing a diffuse
infiltration of an acanthotic epidermis with variable degrees of
spongiosis, intraepidermal blistering, and necrosis.
The neoplastic cells showed a high Ki-67 proliferation index and
expression of CD3, CD8, CD7, CD45RA,
ßF1, and TIA-1 markers, whereas CD2 and CD5 were
frequently lost. Expression of TIA-1 pointed out that these lymphomas
are derived from a cytotoxic T cell subset. The results of this and
other studies reviewed herein suggest that these strongly
epidermotropic primary cutaneous CD8+ cytotoxic T cell lymphomas
represent a distinct type of CTCL with an aggressive clinical
behavior.
This article has been cited by other articles:
 |
|
 |
|
  C. E. Introcaso, E. J. Kim, J. Gardner, J. M. Junkins-Hopkins, C. C. Vittorio, and A. H. Rook CD8+ Epidermotropic Cytotoxic T-Cell Lymphoma With Peripheral Blood and Central Nervous System Involvement Arch Dermatol, August 1, 2008; 144(8): 1027 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Garcia-Herrera, L. Colomo, M. Camos, J. Carreras, O. Balague, A. Martinez, A. Lopez-Guillermo, T. Estrach, and E. Campo Primary Cutaneous Small/Medium CD4+ T-Cell Lymphomas: A Heterogeneous Group of Tumors With Different Clinicopathologic Features and Outcome J. Clin. Oncol., July 10, 2008; 26(20): 3364 - 3371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Csomor, A Bognar, S Benedek, J Sinko, S Fekete, L Krenacs, A Matolcsy, and L Reiniger Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman J. Clin. Pathol., June 1, 2008; 61(6): 770 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. E. Craig and K. A. Foon Flow cytometric immunophenotyping for hematologic neoplasms Blood, April 15, 2008; 111(8): 3941 - 3967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Liu, C. S. Cutler, and A. Z. Young Case 38-2007 -- A 44-Year-Old Woman with Generalized, Painful, Ulcerated Skin Lesions N. Engl. J. Med., December 13, 2007; 357(24): 2496 - 2505. [Full Text] [PDF]
|
|
|
|
|
|
R. Willemze, E. S. Jaffe, G. Burg, L. Cerroni, E. Berti, S. H. Swerdlow, E. Ralfkiaer, S. Chimenti, J. L. Diaz-Perez, L. M. Duncan, et al. WHO-EORTC classification for cutaneous lymphomas Blood, May 15, 2005; 105(10): 3768 - 3785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Bekkenk, P. M. Jansen, C. J. L. M. Meijer, and R. Willemze CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature Ann. Onc., July 1, 2004; 15(7): 1097 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Urosevic, J. Kamarashev, G. Burg, and R. Dummer Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2 Blood, March 1, 2004; 103(5): 1796 - 1798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Bekkenk, M. H. Vermeer, P. M. Jansen, A. M. W. van Marion, M. R. Canninga-van Dijk, P. M. Kluin, M.-L. Geerts, C. J. L. M. Meijer, and R. Willemze Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients Blood, September 15, 2003; 102(6): 2213 - 2219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tracey, R. Villuendas, A. M. Dotor, I. Spiteri, P. Ortiz, J. F. Garcia, J. L. R. Peralto, M. Lawler, and M. A. Piris Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study Blood, August 1, 2003; 102(3): 1042 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Toro, D. J. Liewehr, N. Pabby, L. Sorbara, M. Raffeld, S. M. Steinberg, and E. S. Jaffe Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma Blood, May 1, 2003; 101(9): 3407 - 3412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dummer, J. Kamarashev, W. Kempf, A. C. Haffner, M. Hess-Schmid, and G. Burg Junctional CD8+ Cutaneous Lymphomas With Nonaggressive Clinical Behavior: A CD8+ Variant of Mycosis Fungoides? Arch Dermatol, February 1, 2002; 138(2): 199 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fink-Puches, P. Zenahlik, B. Back, J. Smolle, H. Kerl, and L. Cerroni Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients Blood, February 1, 2002; 99(3): 800 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Vermeer, R. van Doorn, D. Dukers, M. W. Bekkenk, C. J.L.M. Meijer, and R. Willemze CD8+ T Cells in Cutaneous T-Cell Lymphoma: Expression of Cytotoxic Proteins, Fas Ligand, and Killing Inhibitory Receptors and Their Relationship With Clinical Behavior J. Clin. Oncol., December 1, 2001; 19(23): 4322 - 4329. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Kamarashev, G. Burg, M. C. Mingari, W. Kempf, G. Hofbauer, and R. Dummer Differential Expression of Cytotoxic Molecules and Killer Cell Inhibitory Receptors in CD8+ and CD56+ Cutaneous Lymphomas Am. J. Pathol., May 1, 2001; 158(5): 1593 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Lois, P. S. Hiscott, J. Nash, and D. Wong Immunophenotypic Shift in a Case of Mycosis Fungoides With Vitreous Invasion Arch Ophthalmol, December 1, 2000; 118(12): 1692 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Toro, M. Beaty, L. Sorbara, M. L. Turner, J. White, D. W. Kingma, M. Raffeld, and E. S. Jaffe {gamma}{delta} T-Cell Lymphoma of the Skin: A Clinical, Microscopic, and Molecular Study Arch Dermatol, August 1, 2000; 136(8): 1024 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Kadin Cutaneous {gamma}{delta} T-Cell Lymphomas--How and Why Should They Be Recognized? Arch Dermatol, August 1, 2000; 136(8): 1052 - 1054. [Full Text] [PDF]
|
|
|
|
|
|
A. V. Marzano, E. Berti, M. Paulli, and R. Caputo Cytophagic Histiocytic Panniculitis and Subcutaneous Panniculitis-like T-Cell Lymphoma: Report of 7 Cases Arch Dermatol, July 1, 2000; 136(7): 889 - 896. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
